Seagen (Canada)

Seagen (Canada)

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Seagen (Canada), Canada, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

67%


Total
Publications

87


Total Open
Publications

58


Total
Citations

6.5K


Open Access
Percentage

67%


Total
Publications

87


Total Open
Publications

58


Total
Citations

6.5K

Wikipedia

Website

download

Breakdown

27% 26% 11% 36%

Publisher Open

27%

Both

26%

Other Platform Open

11%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

16

Hybrid 21%

9

No Guarantees 42%

18

Other Platform Open

Domain 77%

24

Institution 35%

11

Other Internet 26%

8

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
24
DOI
Other Internet
6
Washington University School of Medicine - Digital Commons@Becker
Institution
2
Unknown Repository
Other Internet
2
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
Digital Access to Libraries
Institution
2
DASH - Digital Access to Scholarship at Harvard
Institution
2
University of Szeged - SZTE Publicatio Repozitórium
Institution
1
University of Michigan - Deep Blue
Institution
1
universiteitleiden.nl OAI-PMH Repository
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share